Clinical Trial Detail

NCT ID NCT02416908
Title Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

acute myeloid leukemia

Therapies

Selinexor

Cladribine + Cytarabine + Plerixafor

Age Groups: adult

No variant requirements are available.